Heather Turner
Family · Easley, SCNPI 1558843664
Payments from drug & device makers
Across 311 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$956
- Lilly USA, LLC$737
- AstraZeneca$722
- Novo Nordisk$579
- Paratek Pharmaceuticals, Inc.$210
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,570 |
| GSK | 44 | $956 |
| Lilly USA, LLC | 38 | $737 |
| AstraZeneca | 25 | $722 |
| Novo Nordisk | 39 | $579 |
| Paratek Pharmaceuticals, Inc. | 5 | $210 |
| Amgen | 11 | $205 |
| Nestle Healthcare Nutrition Inc. | 11 | $174 |
| Boehringer Ingelheim | 9 | $155 |
| Pfizer | 9 | $145 |
| Novartis | 9 | $144 |
| Incyte Corporation | 1 | $140 |
| Avanir Pharmaceuticals, Inc. | 1 | $122 |
| Sanofi | 1 | $122 |
| Sanofi-aventis U.S. LLC | 8 | $113 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| Bayer | 7 | $105 |
| Johnson & Johnson | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Exact Sciences | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Surmodics, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Merck | 1 | $12 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,700 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 59 | $79,849 |
| OzempicSemaglutide | 38 | $37,062 |
| FarxigaDapagliflozin Propanediol | 22 | $21,661 |
| TrulicityDulaglutide | 16 | $18,429 |
| JardianceEmpagliflozin | 17 | $15,720 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $13,940 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $11,856 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $10,845 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $8,582 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $8,279 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $8,199 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $4,426 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 137 | $3,669 |
| Esomeprazole Magnesium | 42 | $2,368 |
| Ezetimibe | 23 | $1,720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $737 | $98,27775 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $722 | $40,78559 claims |
| Novo NordiskOzempic | $579 | $37,06238 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $956 | $35,14860 claims |
| Boehringer IngelheimJardiance | $155 | $15,72017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Easley
- Jessica BellEasley$96K
- Nicole CrawfordEasley$21K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.